HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haein Park Selected Research

Syndecan-2

12/2009Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
10/2009Syndecan-2 regulates the migratory potential of melanoma cells.
11/2005Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
3/2004New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.
2/2003Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells.
8/2002Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haein Park Research Topics

Disease

7Carcinoma (Carcinomatosis)
01/2012 - 08/2002
5Colonic Neoplasms (Colon Cancer)
12/2009 - 08/2002
3Neoplasms (Cancer)
10/2009 - 03/2004
2Sarcoma (Soft Tissue Sarcoma)
01/2015 - 11/2005
2Carcinogenesis
10/2009 - 03/2004
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2016
1Alzheimer Disease (Alzheimer's Disease)
01/2016
1Pathologic Constriction (Stenosis)
01/2016
1Hemoptysis
01/2016
1Inflammation (Inflammations)
01/2016
1Parkinsonian Disorders (Parkinsonism)
01/2016
1Necrosis
01/2016
1Stroke (Strokes)
01/2016
1Nervous System Diseases (Neurological Disorders)
01/2016
1Infections
06/2011
1Nevus (Nevi)
10/2009
1Melanoma (Melanoma, Malignant)
10/2009
1Neoplasm Metastasis (Metastasis)
11/2005
1Lymphoma (Lymphomas)
11/2005
1Fibrosarcoma
11/2005
1Colorectal Neoplasms (Colorectal Cancer)
02/2003

Drug/Important Bio-Agent (IBA)

6Syndecan-2IBA
12/2009 - 08/2002
2Small Interfering RNA (siRNA)IBA
01/2012 - 06/2009
2Tyrosine (L-Tyrosine)FDA Link
06/2011 - 07/2004
2Proteins (Proteins, Gene)FDA Link
12/2009 - 10/2009
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
10/2009 - 11/2005
2Focal Adhesion Protein-Tyrosine KinasesIBA
11/2005 - 07/2004
2Complementary DNA (cDNA)IBA
02/2003 - 08/2002
1ferrous sulfateFDA Link
01/2016
1IronIBA
01/2016
1TabletsIBA
01/2016
1Interleukin-13IBA
01/2015
1Somatomedin Receptors (Somatomedin Receptor)IBA
01/2015
1AntigensIBA
01/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2015
1Chimeric Antigen ReceptorsIBA
01/2015
1Chemotactic FactorsIBA
01/2012
1Macrophage Colony-Stimulating FactorIBA
01/2012
1Matrix Metalloproteinase 7 (Matrilysin)IBA
12/2009
1Messenger RNA (mRNA)IBA
12/2009
1alpha-MSHIBA
10/2009
1Melanins (Melanin)IBA
10/2009
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2009
1Integrin alpha2IBA
06/2009
1matrigelIBA
11/2005
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2005
1adhesion receptorIBA
03/2004
1trichostatin A (A 300)IBA
02/2003
1theasinensin AIBA
02/2003
1Histone Deacetylase InhibitorsIBA
02/2003
1Biological ProductsIBA
08/2002

Therapy/Procedure

1Therapeutics
01/2015